These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12505616)

  • 1. Phosphorylation of alpha-synuclein characteristic of synucleinopathy lesions is recapitulated in alpha-synuclein transgenic Drosophila.
    Takahashi M; Kanuka H; Fujiwara H; Koyama A; Hasegawa M; Miura M; Iwatsubo T
    Neurosci Lett; 2003 Jan; 336(3):155-8. PubMed ID: 12505616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Synuclein is phosphorylated in synucleinopathy lesions.
    Fujiwara H; Hasegawa M; Dohmae N; Kawashima A; Masliah E; Goldberg MS; Shen J; Takio K; Iwatsubo T
    Nat Cell Biol; 2002 Feb; 4(2):160-4. PubMed ID: 11813001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease.
    Chen L; Feany MB
    Nat Neurosci; 2005 May; 8(5):657-63. PubMed ID: 15834418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.
    Giasson BI; Duda JE; Quinn SM; Zhang B; Trojanowski JQ; Lee VM
    Neuron; 2002 May; 34(4):521-33. PubMed ID: 12062037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathology in mice expressing human alpha-synuclein.
    van der Putten H; Wiederhold KH; Probst A; Barbieri S; Mistl C; Danner S; Kauffmann S; Hofele K; Spooren WP; Ruegg MA; Lin S; Caroni P; Sommer B; Tolnay M; Bilbe G
    J Neurosci; 2000 Aug; 20(16):6021-9. PubMed ID: 10934251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
    Iwatsubo T
    J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.
    Lee MK; Stirling W; Xu Y; Xu X; Qui D; Mandir AS; Dawson TM; Copeland NG; Jenkins NA; Price DL
    Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8968-73. PubMed ID: 12084935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Authentically phosphorylated α-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease.
    Sato H; Arawaka S; Hara S; Fukushima S; Koga K; Koyama S; Kato T
    J Neurosci; 2011 Nov; 31(46):16884-94. PubMed ID: 22090514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
    Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
    Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein aggregation and neurodegenerative diseases.
    Ma QL; Chan P; Yoshii M; Uéda K
    J Alzheimers Dis; 2003 Apr; 5(2):139-48. PubMed ID: 12719631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitination of alpha-synuclein.
    Nonaka T; Iwatsubo T; Hasegawa M
    Biochemistry; 2005 Jan; 44(1):361-8. PubMed ID: 15628878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology and neurodegeneration in rodent brain induced by lentiviral vector-mediated overexpression of alpha-synuclein.
    Lauwers E; Debyser Z; Van Dorpe J; De Strooper B; Nuttin B; Baekelandt V
    Brain Pathol; 2003 Jul; 13(3):364-72. PubMed ID: 12946025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation.
    Gispert S; Del Turco D; Garrett L; Chen A; Bernard DJ; Hamm-Clement J; Korf HW; Deller T; Braak H; Auburger G; Nussbaum RL
    Mol Cell Neurosci; 2003 Oct; 24(2):419-29. PubMed ID: 14572463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological biochemistry of alpha-synucleinopathy.
    Iwatsubo T
    Neuropathology; 2007 Oct; 27(5):474-8. PubMed ID: 18018483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
    Giasson BI; Duda JE; Murray IV; Chen Q; Souza JM; Hurtig HI; Ischiropoulos H; Trojanowski JQ; Lee VM
    Science; 2000 Nov; 290(5493):985-9. PubMed ID: 11062131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of alpha-synuclein and its significance].
    Nonaka T; Iwatsubo T; Hasegawa M
    Nihon Rinsho; 2004 Sep; 62(9):1623-8. PubMed ID: 15462375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.
    Dev KK; Hofele K; Barbieri S; Buchman VL; van der Putten H
    Neuropharmacology; 2003 Jul; 45(1):14-44. PubMed ID: 12814657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
    Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M
    Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axonal transport of human alpha-synuclein slows with aging but is not affected by familial Parkinson's disease-linked mutations.
    Li W; Hoffman PN; Stirling W; Price DL; Lee MK
    J Neurochem; 2004 Jan; 88(2):401-10. PubMed ID: 14690528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.